コンテンツへスキップ
Merck
  • Formulation and characterization of lyophilized curcumin solid dispersions for antimicrobial photodynamic therapy (aPDT): studies on curcumin and curcuminoids LII.

Formulation and characterization of lyophilized curcumin solid dispersions for antimicrobial photodynamic therapy (aPDT): studies on curcumin and curcuminoids LII.

Drug development and industrial pharmacy (2014-05-21)
Kristine Opsvik Wikene, Anne Bee Hegge, Ellen Bruzell, Hanne Hjorth Tønnesen
要旨

Bacterial resistance to antibiotics is increasing and alternative antibacterial treatments like antimicrobial photodynamic therapy (aPDT) are needed. Curcumin is under investigation as a potential photosensitizer in aPDT. The purpose of this study was to develop rapidly dissolving formulations of curcumin that could photoinactivate both Gram-positive and Gram-negative bacteria. Curcumin solid dispersions with methyl-β-cyclodextrin and hyaluronic acid (HA), hydroxypropyl methylcellulose (HPMC) or both HA and HPMC were prepared through lyophilization. The lyophilizates were characterized by curcumin drug load [% (w/w)], differential scanning calorimetry, photostability, thermal stability, their ability to form supersaturated solutions and by in vitro photoinactivation of Enterococcus faecalis and Escherichia coli. The lyophilizates were amorphous solid dispersions with a curcumin drug load in the range of 1.4-5.5% (w/w) depending on the included polymer and the ratio between curcumin and the cyclodextrin. The lyophilizates were photolabile, but thermally stable and dissolved rapidly in contact with water to form supersaturated solutions. Selected lyophilizates demonstrated >log 6 reduction of colony forming units/ml of both E. faecalis and E. coli after exposure to low curcumin concentrations (0.5-10 µM) and blue light dose (11-16 J/cm(2)). The high drug load of the lyophilizates, rapid dissolution, ability to form relatively stable supersaturated solutions and the very high phototoxicity towards both E. faecalis and E. coli make these lyophilizates suitable for in vivo aPDT. This treatment with optimized curcumin formulations should be explored as an alternative to topical antibiotics in the treatment of wound infections.

材料
製品番号
ブランド
製品内容

Sigma-Aldrich
塩酸 溶液, 1.0 N, BioReagent, suitable for cell culture
Sigma-Aldrich
塩酸, 36.5-38.0%, BioReagent, for molecular biology
Sigma-Aldrich
クルクミン, from Curcuma longa (Turmeric), powder
Supelco
塩酸 溶液, volumetric, 0.1 M HCl (0.1N), endotoxin free
Sigma-Aldrich
塩酸, SAJ first grade, 35.0-37.0%
Sigma-Aldrich
クルクミン, ≥94% (curcuminoid content), ≥80% (Curcumin)
Sigma-Aldrich
塩酸 溶液, 1 M
Sigma-Aldrich
塩酸, JIS special grade, 35.0-37.0%
Sigma-Aldrich
塩酸 溶液, ~6 M in H2O, for amino acid analysis
Sigma-Aldrich
塩酸 溶液, 0.1 M
Sigma-Aldrich
塩酸 溶液, 6 M
Sigma-Aldrich
塩酸 溶液, 12 M
Sigma-Aldrich
塩化水素 溶液, 3 M in cyclopentyl methyl ether (CPME)
Sigma-Aldrich
塩酸 溶液, 2 M
Sigma-Aldrich
クエン酸 一水和物, ACS reagent, ≥99.0%
Sigma-Aldrich
塩酸 溶液, 0.5 M
Sigma-Aldrich
塩酸 溶液, 0.2 M
Sigma-Aldrich
クエン酸 一水和物, reagent grade, ≥98% (GC/titration)
Sigma-Aldrich
塩酸 溶液, 0.01 M
Sigma-Aldrich
塩酸 溶液, 0.05 M
Sigma-Aldrich
クエン酸 一水和物, puriss. p.a., ACS reagent, reag. ISO, reag. Ph. Eur., buffer substance, 99.5-102%
Sigma-Aldrich
クエン酸 一水和物, JIS special grade, ≥99.5%
Sigma-Aldrich
塩酸 溶液, 0.02 M
Sigma-Aldrich
塩酸, suitable for determination of toxic metals, ≥35.0%
Sigma-Aldrich
塩酸, SAJ super special grade, ≥35.0%
Sigma-Aldrich
塩化水素-エタノール 溶液, 3% in ethanol
Sigma-Aldrich
クエン酸 一水和物, puriss., meets analytical specification of Ph. Eur., BP, USP, E330, 99.5-100.5% (based on anhydrous substance), grit
Sigma-Aldrich
塩化水素-エタノール 溶液, 0.1 M in ethanol
Sigma-Aldrich
クエン酸 一水和物, SAJ first grade, ≥99.5%
Sigma-Aldrich
クエン酸 一水和物, BioXtra, ≥99.5%